Last updated: 23 September 2020 at 7:12pm EST

Manager Ii, Llc Vida Ventur... Net Worth




The estimated Net Worth of Manager Ii, Llc Vida Ventur... is at least $2.61 Million dollars as of 21 September 2020. Manager Ventur owns over 815,000 units of Dyne Therapeutics stock worth over $2,605,425 and over the last 4 years Manager sold DYN stock worth over $0.

Manager Ventur DYN stock SEC Form 4 insiders trading

Manager has made over 1 trades of the Dyne Therapeutics stock since 2020, according to the Form 4 filled with the SEC. Most recently Manager bought 815,000 units of DYN stock worth $15,485,000 on 21 September 2020.

The largest trade Manager's ever made was buying 815,000 units of Dyne Therapeutics stock on 21 September 2020 worth over $15,485,000. On average, Manager trades about 815,000 units every 0 days since 2020. As of 21 September 2020 Manager still owns at least 79,921 units of Dyne Therapeutics stock.

You can see the complete history of Manager Ventur stock trades at the bottom of the page.



Insiders trading at Dyne Therapeutics

Over the last 4 years, insiders at Dyne Therapeutics have traded over $197,573,300 worth of Dyne Therapeutics stock and bought 5,790,447 units worth $92,382,301 . The most active insiders traders include Capital Management, L.P.Kol..., Jason P Rhodes, and Dirk Kersten. On average, Dyne Therapeutics executives and independent directors trade stock every 12 days with the average trade being worth of $3,566,016. The most recent stock trade was executed by Oxana Beskrovnaya on 11 September 2024, trading 2,161 units of DYN stock currently worth $68,914.



What does Dyne Therapeutics do?

Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..



Complete history of Manager Ventur stock trades at Dyne Therapeutics

Insider
Trans.
Transaction
Total value
Manager Ii, Llc Vida Ventur...
Buy $15,485,000
21 Sep 2020


Dyne Therapeutics executives and stock owners

Dyne Therapeutics executives and other stock owners filed with the SEC include: